Drugs

A new research study, published in the journal Brain, explores the occasional link between SARS-CoV-2 and Guillain-Barre syndrome. Following SARS-COV-2 infection, doctors have reported over 90 cases of patients with central and peripheral neurological disorders, including Guillain-Barre syndrome (GBS). GBS is a rare autoimmune disorder where the immune system attacks the nerves, causing muscle weakness
0 Comments
While Botox is most commonly associated with cosmetic procedures, it is also one of the most common preventive treatments for chronic migraine. Clinical trials have found Botox treatment to be effective at reducing the number of migraine days and reducing the severity of migraine attacks in patients with chronic migraine. But what do patients think
0 Comments
Plantar fasciitis is one of the most common heel conditions in adults. Plantar fasciitis occurs when the thick tissues of the heel are inflamed.1 Plantar fasciitis is mainly caused by collagen degeneration in the plantar fascia.2 Its symptoms include pain in the heel during the morning and in the afternoon due to more activity.1 Ten
0 Comments
A recent study from the University of Georgia suggests a common gout medicine could be used to fight COVID-19 infection.1  The medicine, probenecid, is available commercially and has a relatively safe history in clinical use.2  This history is an advantage compared to newly developed drugs because the risk of experiencing adverse effects may be lower.
0 Comments
Eating a handful of walnuts each day may promote cardiovascular health and reduce cardiovascular disease risk, according to a new study. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Low-density lipoprotein (LDL) cholesterol is known as “bad” cholesterol since high levels significantly increase the risk of heart disease and strokes. A
0 Comments
A recent study suggests pharmacists may be a good fit to help people with type 2 diabetes implement dietary changes. Type 2 diabetes is a chronic condition caused when the pancreas does not produce enough insulin to lower blood sugar (2). The prevalence of type 2 diabetes has steadily increased since the 1980s, causing an
0 Comments
Vicoprofen is the brand name for an oral analgesic medication. It is prescribed for short-term management of acute pain, such as post-surgical pain or active cancer treatment, generally for less than ten days.1 Vicoprofen is a fixed-dose combination of hydrocodone bitartrate and ibuprofen. Hydrocodone bitartrate is a semi-synthetic opioid.2 Its immediate-release (IR) form is commercially
0 Comments
Chemical peels are a widely used procedure for the management of acne scars. Also known as chemexfoliation, chemical peels for acne scars involve applying one or more chemical agents, of variable strength, to the skin’s surface. The process creates a controlled chemical-induced injury to the skin. Wounding promotes epidermal and dermal regeneration and tissue remodelling
0 Comments
The term ‘morning sickness’ has been the phrase used to describe nausea and vomiting that is associated with pregnancy for roughly the past 200 years,1 but can be misleading, because ‘morning sickness’ can also occur at night, or any time of the day. Nausea and vomiting occur in up to 74% of pregnancies, with 50%
0 Comments
Researchers at Case Western Reserve University have developed an integrated clinical and CT-based AI nomogram (CIAIN) to predict which COVID-19 patients need a ventilator. CIANE can more precisely identify patients at an earlier disease presentation who may need intubation and invasive mechanical ventilation. The novel approach would decrease disease progression and mortality. The study included a
0 Comments
September 8, 2021 Audience: Health Professional, Pharmacy  September 08, 2021 — Wilmington, MA, Azurity Pharmaceuticals, Inc. (“Azurity”) is voluntarily recalling one lot of Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit (“Firvanq®”) to the consumer level, as some products in the affected lot have been found to incorrectly contain a First Omeprazole (FIRST-PPI)
0 Comments
toripalimab Treatment for Nasopharyngeal Carcinoma Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (“Coherus”, Nasdaq:
0 Comments
Treatment for Wilson’s Disease FDA Acceptance for Filing of New Drug Application (NDA) for Trientine Tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease NDA supported by positive data from Phase 3 CHELATE clinical trial TETA 4-HCl previously granted Orphan Drug Designation for first-line treatment of Wilson’s Disease Paris, France – 02 September 2021 – Orphalan
0 Comments
Tibsovo is the first and only targeted therapy approved for patients with previously treated IDH1-mutated cholangiocarcinoma BOSTON, Aug. 25, 2021 /PRNewswire/ — Servier Pharmaceuticals, a growing leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced today that the U.S. Food and Drug Administration (FDA) approved Tibsovo® (ivosidenib tablets)
0 Comments
tapinarof Treatment for Plaque Psoriasis, Atopic Dermatitis Dermavant Announces FDA Acceptance for Filing of New Drug Application (NDA) for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE) August 10, 2021 –Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today
0 Comments
CAMBRIDGE, Mass. & BEIJING, September 01, 2021–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that Brukinsa (zanubrutinib) has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM). “We are delighted by
0 Comments
palovarotene Treatment for Fibrodysplasia Ossificans Progressiva Ipsen Announces Withdrawal of Palovarotene NDA, Confirming Intention to Resubmit Following Additional Data Analyses Paris (France), Friday 13 August, 2021 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following very recent discussions with the U.S. Food and Drug Administration (FDA), withdrawal of the New Drug Application (NDA) for palovarotene. This
0 Comments
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced that the
0 Comments
Receding gums are gums that have pulled away from the teeth, exposing their root surfaces. This leaves the teeth at risk of decay, infection, and loss. If the recession is severe, it can cause symptoms, such as tooth sensitivity, pain, or infection. Can this process of gum receding be reversed? The gums (gingiva) form the
0 Comments
Treatment for Bladder Cancer Sesen Bio Receives Complete Response Letter from FDA for Vicineum (oportuzumab monatox-qqrs) CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aug. 13, 2021– Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding
0 Comments
FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic Invega Hafyera (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia
0 Comments
September 1, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy This information is an update to the FDA Drug Safety Communication issued on February 4, 2021. FDA also previously communicated about the safety clinical trial with Xeljanz, Xeljanz XR (tofacitinib) in February 2019 and July 2019 What safety concern is FDA announcing? Based on a completed
0 Comments
elamipretide Treatment for Barth Syndrome Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome BOSTON, Aug. 24, 2021 /PRNewswire/ – Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced the submission of a New Drug Application (NDA)
0 Comments
Beets, and in particular beetroot juice, are known to have many health benefits. For example, beets are great for your cardiovascular well-being.1 That is, eating this vegetable promotes a healthy heart and a good flow of blood throughout the body. Beets may also have some benefits for diabetes. Beets also have a high fibre content,
0 Comments
ATLANTA, Aug. 30, 2021 /PRNewswire/ — UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution, and injection to treat partial-onset seizures in patients as young as one month of age.2 This is the first time that the IV formulation of Briviact
0 Comments